Detalhe da pesquisa
1.
Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
BMC Cancer
; 24(1): 88, 2024 Jan 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38229045
2.
Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
BMC Cancer
; 15: 785, 2015 Oct 24.
Artigo
Inglês
| MEDLINE | ID: mdl-26499463
3.
4EBP1-mediated SLC7A11 protein synthesis restrains ferroptosis triggered by MEK inhibitors in advanced ovarian cancer.
JCI Insight
; 2024 Jun 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38842940
4.
Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial.
Clin Transl Oncol
; 25(1): 256-268, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36115931
5.
Role of Lymphadenectomy During Interval Debulking Surgery Performed After Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer.
Front Oncol
; 11: 646135, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33842358
6.
Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.
J Immunother Cancer
; 9(5)2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34011535
7.
Minimally invasive surgery vs laparotomy for early stage cervical cancer: A propensity score-matched cohort study.
Cancer Med
; 9(24): 9236-9245, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33236825
8.
Comparison of PARPis with Angiogenesis Inhibitors and Chemotherapy for Maintenance in Ovarian Cancer: A Network Meta-Analysis.
Adv Ther
; 36(12): 3368-3380, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31599396
9.
Expression of COL6A1 predicts prognosis in cervical cancer patients.
Am J Transl Res
; 8(6): 2838-44, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27398167
10.
Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.
Int J Clin Exp Pathol
; 7(1): 280-7, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24427349
11.
Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial
Clin. transl. oncol. (Print)
; 25(1): 256-268, ene. 2023.
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-215839